NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1409137295|ref|NP_001351557|]
View 

tubulin polyglutamylase TTLL5 isoform 7 [Mus musculus]

Protein Classification

ATP-grasp domain-containing protein( domain architecture ID 106900)

ATP-grasp domain-containing protein may be related to carbamoyl phosphate synthetase and predicted to be involved in the biosynthesis of a ribonucleoside involved in stress response

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
CPSase_L_D2 super family cl17255
Carbamoyl-phosphate synthase L chain, ATP binding domain; Carbamoyl-phosphate synthase ...
24-223 1.17e-67

Carbamoyl-phosphate synthase L chain, ATP binding domain; Carbamoyl-phosphate synthase catalyzes the ATP-dependent synthesis of carbamyl-phosphate from glutamine or ammonia and bicarbonate. This important enzyme initiates both the urea cycle and the biosynthesis of arginine and/or pyrimidines. The carbamoyl-phosphate synthase (CPS) enzyme in prokaryotes is a heterodimer of a small and large chain. The small chain promotes the hydrolysis of glutamine to ammonia, which is used by the large chain to synthesize carbamoyl phosphate. See pfam00988. The small chain has a GATase domain in the carboxyl terminus. See pfam00117. The ATP binding domain (this one) has an ATP-grasp fold.


The actual alignment was detected with superfamily member pfam03133:

Pssm-ID: 473076  Cd Length: 291  Bit Score: 229.53  E-value: 1.17e-67
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1409137295   24 PNQISLEENI---LVSRYINNPLLIDDFKFDVRLYVLVTSYDPLVIYLYEEGLARFATVRYDQGSKNIRNQFMHLTNYSV 100
Cdd:pfam03133   88 LSQIPKWSQSrplVVQKYIERPLLIDGRKFDIRLYVLVTSVNPLRVYVYREGLLRFASVKYSPSSSDLDDVEMHLTNYSI 167
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1409137295  101 NKKsgdYVSCDDPEVEDYGNKWSMSAMLRYLkqEGKDTTALMAHVEDLIIKTIISAElaiATACKTFVPHRSSCFELYGF 180
Cdd:pfam03133  168 QKK---SSSLNEDYNEPHGHKWSLQNFWKYL--EEKDKDEIWLEIESIIIKTILAAE---VEASRLNVQPLPNCFELYGF 239
                          170       180       190       200
                   ....*....|....*....|....*....|....*....|...
gi 1409137295  181 DVLIDNTLKPWLLEVNLSPSLACDAPLDLKIKASMISDMFTVV 223
Cdd:pfam03133  240 DFMIDENLKPWLLEVNSSPSLHSTTKLDARLKEQLIDDVLNSV 282
 
Name Accession Description Interval E-value
TTL pfam03133
Tubulin-tyrosine ligase family; Tubulins and microtubules are subjected to several ...
24-223 1.17e-67

Tubulin-tyrosine ligase family; Tubulins and microtubules are subjected to several post-translational modifications of which the reversible detyrosination/tyrosination of the carboxy-terminal end of most alpha-tubulins has been extensively analysed. This modification cycle involves a specific carboxypeptidase and the activity of the tubulin-tyrosine ligase (TTL). The true physiological function of TTL has so far not been established. Tubulin-tyrosine ligase (TTL) catalyzes the ATP-dependent post-translational addition of a tyrosine to the carboxy terminal end of detyrosinated alpha-tubulin. In normally cycling cells, the tyrosinated form of tubulin predominates. However, in breast cancer cells, the detyrosinated form frequently predominates, with a correlation to tumour aggressiveness. On the other hand, 3-nitrotyrosine has been shown to be incorporated, by TTL, into the carboxy terminal end of detyrosinated alpha-tubulin. This reaction is not reversible by the carboxypeptidase enzyme. Cells cultured in 3-nitrotyrosine rich medium showed evidence of altered microtubule structure and function, including altered cell morphology, epithelial barrier dysfunction, and apoptosis. Bacterial homologs of TTL are predicted to form peptide tags. Some of these are fused to a 2-oxoglutarate Fe(II)-dependent dioxygenase domain.


Pssm-ID: 397308  Cd Length: 291  Bit Score: 229.53  E-value: 1.17e-67
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1409137295   24 PNQISLEENI---LVSRYINNPLLIDDFKFDVRLYVLVTSYDPLVIYLYEEGLARFATVRYDQGSKNIRNQFMHLTNYSV 100
Cdd:pfam03133   88 LSQIPKWSQSrplVVQKYIERPLLIDGRKFDIRLYVLVTSVNPLRVYVYREGLLRFASVKYSPSSSDLDDVEMHLTNYSI 167
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1409137295  101 NKKsgdYVSCDDPEVEDYGNKWSMSAMLRYLkqEGKDTTALMAHVEDLIIKTIISAElaiATACKTFVPHRSSCFELYGF 180
Cdd:pfam03133  168 QKK---SSSLNEDYNEPHGHKWSLQNFWKYL--EEKDKDEIWLEIESIIIKTILAAE---VEASRLNVQPLPNCFELYGF 239
                          170       180       190       200
                   ....*....|....*....|....*....|....*....|...
gi 1409137295  181 DVLIDNTLKPWLLEVNLSPSLACDAPLDLKIKASMISDMFTVV 223
Cdd:pfam03133  240 DFMIDENLKPWLLEVNSSPSLHSTTKLDARLKEQLIDDVLNSV 282
 
Name Accession Description Interval E-value
TTL pfam03133
Tubulin-tyrosine ligase family; Tubulins and microtubules are subjected to several ...
24-223 1.17e-67

Tubulin-tyrosine ligase family; Tubulins and microtubules are subjected to several post-translational modifications of which the reversible detyrosination/tyrosination of the carboxy-terminal end of most alpha-tubulins has been extensively analysed. This modification cycle involves a specific carboxypeptidase and the activity of the tubulin-tyrosine ligase (TTL). The true physiological function of TTL has so far not been established. Tubulin-tyrosine ligase (TTL) catalyzes the ATP-dependent post-translational addition of a tyrosine to the carboxy terminal end of detyrosinated alpha-tubulin. In normally cycling cells, the tyrosinated form of tubulin predominates. However, in breast cancer cells, the detyrosinated form frequently predominates, with a correlation to tumour aggressiveness. On the other hand, 3-nitrotyrosine has been shown to be incorporated, by TTL, into the carboxy terminal end of detyrosinated alpha-tubulin. This reaction is not reversible by the carboxypeptidase enzyme. Cells cultured in 3-nitrotyrosine rich medium showed evidence of altered microtubule structure and function, including altered cell morphology, epithelial barrier dysfunction, and apoptosis. Bacterial homologs of TTL are predicted to form peptide tags. Some of these are fused to a 2-oxoglutarate Fe(II)-dependent dioxygenase domain.


Pssm-ID: 397308  Cd Length: 291  Bit Score: 229.53  E-value: 1.17e-67
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1409137295   24 PNQISLEENI---LVSRYINNPLLIDDFKFDVRLYVLVTSYDPLVIYLYEEGLARFATVRYDQGSKNIRNQFMHLTNYSV 100
Cdd:pfam03133   88 LSQIPKWSQSrplVVQKYIERPLLIDGRKFDIRLYVLVTSVNPLRVYVYREGLLRFASVKYSPSSSDLDDVEMHLTNYSI 167
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1409137295  101 NKKsgdYVSCDDPEVEDYGNKWSMSAMLRYLkqEGKDTTALMAHVEDLIIKTIISAElaiATACKTFVPHRSSCFELYGF 180
Cdd:pfam03133  168 QKK---SSSLNEDYNEPHGHKWSLQNFWKYL--EEKDKDEIWLEIESIIIKTILAAE---VEASRLNVQPLPNCFELYGF 239
                          170       180       190       200
                   ....*....|....*....|....*....|....*....|...
gi 1409137295  181 DVLIDNTLKPWLLEVNLSPSLACDAPLDLKIKASMISDMFTVV 223
Cdd:pfam03133  240 DFMIDENLKPWLLEVNSSPSLHSTTKLDARLKEQLIDDVLNSV 282
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH